Benzodiazepines are the most commonly used and effective treatment of
symptoms of anxiety, but they have drawbacks. The current challenge is
to discover partial agonists that do not cause the adverse effects ch
aracteristic of benzodiazepines. The authors discuss the main drugs th
at are used in the treatment of acute anxiety and some of the current
or future alternatives and also highlight several problems that need t
o be resolved in the development of new anxiolytics.